A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
Thursday, January 5 | 2-3 p.m. ET | Virtual and In-Person The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating […]
Thursday, January 12 | 12-1 p.m. ET | Virtual The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and […]
Friday, January 20 | 1-2 pm ET (12-1 pm CT) | Virtual The University of Minnesota College of Pharmacy invites all actively practicing clinicians to join their Pharmacogenomics (PGx) ECHO […]
Tuesday, January 24 | 12-1 pm ET | Virtual DCRI Research Forum: Unlocking the Promise of Gene Therapy Peter Marks, MD, PhD Director, Center for Biologics Evaluation and Research U.S. […]
Wednesday, January 25 | 1-4 p.m. EST | Virtual Join a lively discussion of social and behavioral genetics and genomics, its benefits, limitations and potential for misuse. Panelists will discuss […]
Thursday, January 26 | 12-1 p.m. ET | Virtual The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and […]
Thursday, February 9 | 12-1 p.m. ET | Virtual The Duke Precision Medicine Program Forum Series features speakers from Duke and beyond working on innovative research in clinical, translational, and […]
Thursday, February 9 | 12-2 pm ET | Virtual In this mini symposium, the CDC Office of Genomics and Precision Public Health will reflect on 25 years of progress in […]
Monday, February 13 | 11:30 a.m.-6 p.m. | Online The National Human Genome Research Institute will hold the 98th Meeting of National Advisory Council for Human Genome Research. The open […]
Thursday, February 16 | 3:30 - 4:30 p.m. ET | Online & Bethesda, MD C. Jimmy Lin, M.D., Ph.D., MHS is the Founder and Chief Executive Officer of Rare Genomics […]
GMKB